Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MAgic Touch™ Intervention Leap for Dialysis Access (MATILDA) Trial

NCT04698512 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.

NCT NCT04698512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04698512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MAgic Touch™ Intervention Leap for Dialysis Access (MATILDA) Trial
Lead sponsor
Singapore General Hospital
Phase
Observational
Overall status
Completed
Start date
May 21, 2019
Completion date
January 30, 2021
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dialysis access malfunction, end stage renal disease, end stage renal failure on dialysis, fistulas arteriovenous, stenosis